August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Can a Shingles Vaccine Shield the Heart?

New research suggests herpes zoster vaccination may offer unexpected cardiovascular protection beyond preventing painful skin outbreaks.

Conexiant

August 28, 2025

Study Identifies Age-Specific Prediabetes Mortality Risk

Researchers found in over 38,000 US adults that prediabetes was linked to higher mortality risk only in those aged 20 to 54 years.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant

August 26, 2025

Mediterranean Diet: A Simple Twist Boosts Results

A small change to the eating plan may beat the standard Mediterranean diet alone.

Conexiant

August 25, 2025

What Does Xlear’s Lawsuit Mean for Physicians?

Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing.

KFF Health News

August 21, 2025

Screen Time May Raise Cardiometabolic Risk in Youth

Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.

Conexiant

August 18, 2025

FDA Approves New Indication for Wegovy

Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.

Conexiant